Lindbrook Capital, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,721
+90.1%
278
+334.4%
0.00%
Q2 2023$3,009
+37.9%
64
+23.1%
0.00%
Q1 2023$2,182
+2.2%
52
-7.1%
0.00%
Q4 2022$2,136
-76.3%
56
-76.0%
0.00%
-100.0%
Q3 2022$9,000
+350.0%
233
+219.2%
0.00%
Q1 2022$2,0000.0%73
+32.7%
0.00%
-100.0%
Q3 2021$2,0000.0%55
+37.5%
0.00%
Q2 2021$2,000
-50.0%
40
-23.1%
0.00%
-100.0%
Q1 2021$4,0000.0%520.0%0.00%0.0%
Q4 2020$4,000
+33.3%
520.0%0.00%0.0%
Q3 2020$3,000
+50.0%
520.0%0.00%0.0%
Q2 2020$2,000520.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 409,000$17,399,0004.82%
Palo Alto Investors LP 781,730$33,255,0002.12%
DAFNA Capital Management LLC 180,306$7,670,0001.93%
Boxer Capital, LLC 1,094,000$46,539,0001.81%
Deep Track Capital, LP 500,000$21,270,0001.50%
Bellevue Group AG 3,228,004$137,319,0001.42%
EcoR1 Capital, LLC 940,636$40,015,0001.28%
Deep Track Capital, LP 400,000$17,016,0001.20%
Artal Group S.A. 1,000,000$42,540,0001.15%
SECTOR GAMMA AS 98,904$4,207,0000.99%
View complete list of SAGE THERAPEUTICS INC shareholders